Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Postmenopausal vaginal atrophy (PVA) refers to reduction in estrogen production after menopause and this condition is also called as vaginal atrophy. Less estrogen leads to thinning, drying, and decreased elasticity of vaginal tissues. Various other factors that lead to decrease in estrogen levels include perimenopause during breast feeding, surgical menopause, pelvic radiation therapy, and chemotherapy.
The report details the trend, potential and market size of Postmenopausal Vaginal Atrophy Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Postmenopausal Vaginal Atrophy Drugsmarket, defines the market attractiveness level of Postmenopausal Vaginal Atrophy Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Postmenopausal Vaginal Atrophy Drugs industry, describes the types of Postmenopausal Vaginal Atrophy Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Postmenopausal Vaginal Atrophy Drugs market and the development prospects and opportunities of Postmenopausal Vaginal Atrophy Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Postmenopausal Vaginal Atrophy Drugs market in Chapter 13.
By Player:
Shionogi & Company
Allergan plc
Novo Nordisk A/S
Actavis plc
By Type:
Premarin
Vagifem
Estrace
Estring
Femring
By End-User:
Vaginal Gels
Creams
Tablets
Rings
Patches
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Postmenopausal Vaginal Atrophy Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Postmenopausal Vaginal Atrophy Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Postmenopausal Vaginal Atrophy Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Postmenopausal Vaginal Atrophy Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Postmenopausal Vaginal Atrophy Drugs Market Analysis and Outlook to 2022
-
7.1 Global Postmenopausal Vaginal Atrophy Drugs Consumption (2017-2022)
-
7.2 United States Postmenopausal Vaginal Atrophy Drugs Consumption (2017-2022)
-
7.3 Europe Postmenopausal Vaginal Atrophy Drugs Consumption (2017-2022)
-
7.4 China Postmenopausal Vaginal Atrophy Drugs Consumption (2017-2022)
-
7.5 Japan Postmenopausal Vaginal Atrophy Drugs Consumption (2017-2022)
-
7.6 India Postmenopausal Vaginal Atrophy Drugs Consumption (2017-2022)
-
7.7 South Korea Postmenopausal Vaginal Atrophy Drugs Consumption (2017-2022)
8 Region and Country-wise Postmenopausal Vaginal Atrophy Drugs Market Analysis and Outlook to 2028
-
8.1 Global Postmenopausal Vaginal Atrophy Drugs Consumption Forecast (2022-2028)
-
8.2 United States Postmenopausal Vaginal Atrophy Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Postmenopausal Vaginal Atrophy Drugs Consumption Forecast (2022-2028)
-
8.4 China Postmenopausal Vaginal Atrophy Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Postmenopausal Vaginal Atrophy Drugs Consumption Forecast (2022-2028)
-
8.6 India Postmenopausal Vaginal Atrophy Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Postmenopausal Vaginal Atrophy Drugs Consumption Forecast (2022-2028)
9 Global Postmenopausal Vaginal Atrophy Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Postmenopausal Vaginal Atrophy Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Premarin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Vagifem Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Estrace Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Estring Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Femring Consumption and Growth Rate (2017-2022)
-
9.2 Global Postmenopausal Vaginal Atrophy Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Vaginal Gels Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Creams Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Rings Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Patches Consumption and Growth Rate (2017-2022)
10 Global Postmenopausal Vaginal Atrophy Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Postmenopausal Vaginal Atrophy Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Premarin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Vagifem Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Estrace Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Estring Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Femring Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Postmenopausal Vaginal Atrophy Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Vaginal Gels Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Creams Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Rings Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Patches Consumption Forecast and Growth Rate (2022-2028)
11 Global Postmenopausal Vaginal Atrophy Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Postmenopausal Vaginal Atrophy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Postmenopausal Vaginal Atrophy Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Postmenopausal Vaginal Atrophy Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Postmenopausal Vaginal Atrophy Drugs Market Competitive Analysis
-
14.1 Shionogi & Company
-
14.1.1 Shionogi & Company Company Details
-
14.1.2 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Product and Service
-
14.2 Allergan plc
-
14.2.1 Allergan plc Company Details
-
14.2.2 Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Allergan plc Postmenopausal Vaginal Atrophy Drugs Product and Service
-
14.3 Novo Nordisk A/S
-
14.3.1 Novo Nordisk A/S Company Details
-
14.3.2 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Product and Service
-
14.4 Actavis plc
-
14.4.1 Actavis plc Company Details
-
14.4.2 Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Actavis plc Postmenopausal Vaginal Atrophy Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Postmenopausal Vaginal Atrophy Drugs
-
Figure Postmenopausal Vaginal Atrophy Drugs Picture
-
Table Global Postmenopausal Vaginal Atrophy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption by Country (2017-2022)
-
Figure United States Postmenopausal Vaginal Atrophy Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Postmenopausal Vaginal Atrophy Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Postmenopausal Vaginal Atrophy Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Postmenopausal Vaginal Atrophy Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Postmenopausal Vaginal Atrophy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Postmenopausal Vaginal Atrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Postmenopausal Vaginal Atrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Postmenopausal Vaginal Atrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Postmenopausal Vaginal Atrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Postmenopausal Vaginal Atrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Premarin Consumption and Growth Rate (2017-2022)
-
Figure Global Vagifem Consumption and Growth Rate (2017-2022)
-
Figure Global Estrace Consumption and Growth Rate (2017-2022)
-
Figure Global Estring Consumption and Growth Rate (2017-2022)
-
Figure Global Femring Consumption and Growth Rate (2017-2022)
-
Figure Global Vaginal Gels Consumption and Growth Rate (2017-2022)
-
Figure Global Creams Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Rings Consumption and Growth Rate (2017-2022)
-
Figure Global Patches Consumption and Growth Rate (2017-2022)
-
Figure Global Premarin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vagifem Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Estrace Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Estring Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Femring Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaginal Gels Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Creams Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rings Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Patches Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Postmenopausal Vaginal Atrophy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Postmenopausal Vaginal Atrophy Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Shionogi & Company (Foundation Year, Company Profile and etc.)
-
Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Product and Service
-
Table Allergan plc (Foundation Year, Company Profile and etc.)
-
Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Product and Service
-
Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Product and Service
-
Table Actavis plc (Foundation Year, Company Profile and etc.)
-
Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Product and Service
-
